Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

A new topical finasteride formulation effectively promotes hair growth with fewer side effects.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Annurca apple extract improved hair growth in mice and could potentially prevent hair loss.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Deer antler products improved hair growth and thickness for people with hair loss.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Upadacitinib is effective and safe for long-term treatment of alopecia areata, especially for those with an atopic background.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

The patch effectively promotes hair growth for alopecia areata without pain.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.